[Role of apha-blockaders in the treatment of prostatism].
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011467:Prostate / Q000032:analysis; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D011942:Receptors, Adrenergic, alpha / Q000032:analysis / Q000187:drug effects; D014551:Urinary Tract / Q000187:drug effects; D014554:Urination / Q000187:drug effects; D014555:Urination Disorders / Q000188:drug therapy
D000317:Adrenergic alpha-Antagonists; D011942:Receptors, Adrenergic, alpha
Place des alpha-bloquants dans le traitement du prostatisme.